Sign up
Quantellect · Congress · Trade Detail
TO: LABSMedipharm Labs Corp
RepublicanHouse

Michael T. McCaul sold Medipharm Labs Corp (TO: LABS)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 93 trades in Medipharm Labs Corp (LABS) since 2014, 51 purchases and 42 sales, worth an estimated $3.4M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Michael T. McCaul sold $15,001 - $50,000 of Medipharm Labs Corp (TO: LABS) on December 18, 2017. Since that trade, LABS is up +7.14% against the S&P 500 up +209.02%, an outperformance of -201.88%.

Across these filings, Michael T. McCaul has been a net buyer of LABS (a buy-to-sell ratio of 1.21). The most recent disclosed LABS transaction shown was dated August 15, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

LABS trades
93
Disclosed Vol
$3.4M
Buys
51
55%
Sells
42
45%
Buy / Sell
1.21
ratio
First → Last
2014–2025

Michael T. McCaul's LABS trades vs the price

LABS is up +7.14% since Michael T. McCaul sold on December 18, 2017, versus +209.02% for the S&P 500.

Performance since this trade

Price change since trade
+7.14%
S&P 500 change since trade
+209.02%
Outperformance vs S&P 500
-201.88%

All Michael T. McCaul LABS trades

TradedTypeSizeReturnEst. profit
August 15, 2025BUY$0.08N/A-$500
July 31, 2025SELL$0.07N/A
June 27, 2025SELL$0.07N/A
June 16, 2025SELL$0.08N/A
November 19, 2024SELL$0.07N/A
November 19, 2024SELL$0.07N/A
November 4, 2024BUY$0.07N/A+$5K
August 9, 2024BUY$0.07N/A+$5K
August 9, 2024BUY$0.07N/A+$5K
December 16, 2020SELL$0.58N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & LABS trading FAQ

Is it legal for Michael T. McCaul to trade Medipharm Labs Corp (LABS) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Medipharm Labs Corp (LABS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul sell LABS?

Michael T. McCaul disclosed a sale of $15,001 - $50,000 of Medipharm Labs Corp (LABS) on December 18, 2017, according to public STOCK Act filings.

How has LABS performed since Michael T. McCaul's trade?

Since Michael T. McCaul sold LABS on December 18, 2017, the stock is up +7.14%, versus +209.02% for the S&P 500 over the same period, an outperformance of -201.88%.

How many times has Michael T. McCaul traded LABS?

Michael T. McCaul has disclosed 93 LABS trades since 2014 (51 purchases and 42 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional LABS trades?

Quantellect tracks every disclosed congressional trade in Medipharm Labs Corp (LABS) on the Medipharm Labs Corp congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's LABS tradesAll congressional filings for Medipharm Labs CorpMichael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.